Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinyue Granule
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xinyue Granule is a multi-component Traditional Chinese Medicine (TCM) formulation developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of depression and mild cognitive impairment (MCI), specifically targeting patients with the "Qi and Yin deficiency" syndrome. The formula is composed of several botanical ingredients, including *Panax quinquefolius* (American ginseng), *Ophiopogon japonicus*, *Schisandra chinensis*, *Hypericum perforatum* (St. John's Wort), and *Albizia julibrissin*. Mechanistically, Xinyue Granule is thought to exert its therapeutic effects by increasing the expression of brain-derived neurotrophic factor (BDNF), modulating the hypothalamic-pituitary-adrenal (HPA) axis, and regulating monoamine neurotransmitters such as serotonin and norepinephrine. It is currently utilized as a registered hospital preparation in China and has been evaluated in several clinical trials for its efficacy in improving cognitive function and alleviating depressive symptoms.
- Brand names
- Xinyue Granule
- Other names
- Xinyue Keli欣悦颗粒
02
Targets
5-HT (Serotonin receptors)GR (Glucocorticoid receptor)BDNF (Brain-derived neurotrophic factor)
Beyond the preview
Go deeper on Xinyue Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinyue Granule.